We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-9.32%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$57.5M
AUM Growth
-$5.96M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$24M
$43.7M 75.9%
99,113
MRSN
2
DELISTED
Mersana Therapeutics
MRSN
$13.4M 23.36%
32,721
SENS icon
3
Senseonics Holdings Inc
SENS
$254M
$425K 0.74%
7,980

Similar funds

Rho Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Rho Capital Partners held 3 positions worth $57.5M, down 9.4% from $63.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Rho Capital Partners's ten largest holdings make up 100% of its $57.5M portfolio in Q4 2017.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q4 2017.
  • Rho Capital Partners's portfolio value fell 9.4% quarter-over-quarter to $57.5M.

Based on Rho Capital Partners's 13F filing for Q4 2017, filed 13 Feb 2018.